Thursday, GoodRx Holdings (NASDAQ:GDRX) reported a first-quarter adjusted EPS of $0.08, which was in line with the consensus and higher than the $0.07 reported a year ago.
The company reported sales of $197.88 million, beating the consensus of $196.08 million.
Revenue and Adjusted Revenue increased 8% to $197.9 million compared to $184.0 million.
Prescription transactions revenue increased 8% to $145.4 million, primarily driven by a 10% increase in Monthly Active Consumers, principally from organic growth.
Subscription revenue decreased 6% to $22.6 million, primarily ...